Elisabeth Andreadou

Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration

Elisabeth Andreadou, Chryssoula Nikolaou, Filippos Gournaras et al. · Clinical Neurology and Neurosurgery · 2009 · 140 citations

Disease Duration, Urological Research, Chronic Kidney Disease +2

Circulating interleukin-15 and RANTES chemokine in Parkinson’s disease

Michael Rentzos, Christoforos Nikolaou, Elisabeth Andreadou et al. · Acta Neurologica Scandinavica · 2007 · 119 citations

Circulating interleukin-10 and interleukin-12 in Parkinson’s disease

Michael Rentzos, Christoforos Nikolaou, Elisabeth Andreadou et al. · Acta Neurologica Scandinavica · 2009 · 98 citations

Differential Expression of Cytokines and Chemokines in Human Monocytes Induced by Lipid Formulations of Amphotericin B

Maria Simitsopoulou, Emmanuel Roilides, John Dotis et al. · Antimicrobial Agents and Chemotherapy · 2005 · 64 citations · Full text

Immunology, Immunotherapy, Immune System +19

Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature

Elisabeth Andreadou, Elissavet Kemanetzoglou, Ch. Brokalaki et al. · Case Reports in Neurological Medicine · 2013 · 60 citations · Full text

Coincidental Association, Neurological Disorder, Clinical Neurology +20